Is Oculis Holding (NasdaqGM:OCS) Fairly Valued? A Closer Look After Recent Share Movement [Yahoo! Finance]
Oculis Holding AG - Ordinary shares (OCS)
Company Research
Source: Yahoo! Finance
The company, which focuses on ophthalmic treatments, has delivered strong annual revenue growth, along with improved net income figures. See our latest analysis for Oculis Holding. Oculis Holding's share price has been on quite a ride. After a strong run-up year-to-date, there was a recent dip over the past month, but longer-term momentum remains solid. With a 38.6% total shareholder return over the past year and a stellar 96% total return over three years, optimism around its pipeline and recent milestones is clearly still driving enthusiasm among investors. If you're tracking healthcare breakthroughs, it's an ideal time to check out other fast-moving innovators with our See the full list for free. With shares still trading below analyst price targets despite impressive revenue growth, the question now is whether Oculis Holding is a bargain or if investors have already factored in its future prospects. Price-to-Book Ratio of 6.2x: Is it justified? Oculis Holding trades at
Show less
Read more
Impact Snapshot
Event Time:
OCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCS alerts
High impacting Oculis Holding AG - Ordinary shares news events
Weekly update
A roundup of the hottest topics
OCS
News
- Oculis (NASDAQ:OCS) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $55.00 price target on the stock.MarketBeat
- Oculis (NASDAQ:OCS) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=OCS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from MarketBeat
- Oculis (NASDAQ:OCS) had its price target lowered by analysts at Bank of America Corporation from $30.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
- Oculis (NASDAQ:OCS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.MarketBeat
- Oculis (NASDAQ:OCS) had its price target raised by analysts at HC Wainwright from $36.00 to $42.00. They now have a "buy" rating on the stock.MarketBeat
OCS
Earnings
- 11/10/25 - Beat
OCS
Sec Filings
- 12/1/25 - Form 424B3
- 11/14/25 - Form SCHEDULE
- 11/10/25 - Form F-3
- OCS's page on the SEC website